Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ((2R,7aS) 2 fluorohexahydro 1H pyrrolazin 7a yl)methanol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 5-step synthesis of KRAS G12D inhibitor intermediate 1 from L-proline. Reduces cost and complexity compared to ozonolysis routes.
Patent CN115894503A details a streamlined 5-step synthesis of a key pyrrolizine intermediate from L-proline, offering significant cost reduction and safer processing for API manufacturing.